Overdiagnosis in lung cancer screening: why modelling is essential
- PMID: 26071497
- PMCID: PMC4978857
- DOI: 10.1136/jech-2014-204079
Overdiagnosis in lung cancer screening: why modelling is essential
Keywords: CANCER; Cancer epidemiology; SCREENING.
Conflict of interest statement
KtH and HJdK are members of the Cancer Intervention and Surveillance Modelling Network (CISNET) Lung working group. HJdK is the principal investigator of the Dutch-Belgian Lung Cancer Screening Trial (Nederlands-Leuvens Longkanker Screenings onderzoek; the NELSON trial). KtH is a researcher affiliated with the NELSON trial.
Figures
References
-
- Ruano-Ravina A, Heleno B, Fernández-Villar A. Lung cancer screening with low-dose CT (LDCT), or when a public health intervention is beyond the patient’s benefit. J Epidemiol Community Health. 2015;69:99–100. - PubMed
-
- Moyer VA. Screening for lung cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2014;160:330–8. - PubMed
-
- Centers for Medicare & Medicaid Services. ((CAG-00439N)).Proposed Decision Memo for Screening for Lung Cancer with Low Dose Computed Tomography (LDCT) 2014 http://www.cms.gov/medicare-coverage-database/details/nca-proposed-decis... (accessed 20 Nov 2014)
-
- Habbema JDF, Wilt TJ, Etzioni R, et al. Models in the development of clinical practice guidelines models in the development of clinical practice guidelines. Ann Intern Med. 2014;161:812–18. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical